Amneal Sees Key Suboxone Product-Hopping Claims Advance
A Pennsylvania federal judge on Wednesday advanced the bulk of generic-drug manufacturer Amneal's claims in its suit accusing drugmaker Indivior PLC of embarking on a product-hopping scheme to stave off generic...To view the full article, register now.
Already a subscriber? Click here to view full article